Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Is The Diagnostic Biomarkers Market Expected To Grow In Terms Of Size?

In recent times, the diagnostic biomarkers industry has experienced a swift expansion. The market size is projected to increase from $65.25 billion in 2024 to $75.46 billion in 2025 at a compound annual growth rate (CAGR) of 15.7%. Factors contributing to the surge in the historic period include the escalating occurrences of chronic illnesses, progress in omics technologies, heightened demand for customised medication, an increase in cognizance of early illness detection, and a rise in the adoption of non-invasive diagnostic procedures.

In the coming years, the diagnostic biomarkers market is predicted to experience significant growth, expanding to $135.36 billion by 2029 with an annual growth rate of 15.7%. This surge in market value during the predicted period can be associated with the increasing utilization of liquid biopsy techniques, escalating investments in biomarkers studies, an intensified focus on precision medicine, and burgeoning applications in the area of neurodegenerative diseases. Key trends projected for the forecast period encompass progresses in artificial intelligence and machine learning, the integration of multi-omics tactics, development of point-of-care diagnostic equipment, the transition towards digital biomarkers, increasing usage of wearable health monitoring apparatus, and an enhanced emphasis on the validation and standardization of biomarkers.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21171&type=smp

What Market Forces Are Contributing To The Growth Of The Diagnostic Biomarkers Market?

The surge in cancer incidence propels the expansion of the diagnostic biomarkers market. The rise in cancer cases can be attributed to aspects like the aging demographic, changes in lifestyle, environmental hazards, and enhanced diagnostic proficiency. Diagnostic biomarkers have a significant part in battling cancer as they facilitate early detection, precise diagnosis, and tailor-made treatment plans, thus elevating the patient’s outcome. For example, in January 2024, the American Cancer Society, a nonprofit cancer advocacy group based in the US, announced an increase in the count of cancer cases to 2,001,140 from the previous year’s 1,958,310, marking a 2.19% growth. This escalating incidence of cancer is fueling the expansion of the diagnostic biomarkers market.

How Is The Diagnostic Biomarkers Market Segmented Across Key Categories?

The diagnostic biomarkersmarket covered in this report is segmented –

1) By Product: Safety Biomarkers; Efficacy Biomarkers; Validation Biomarkers

2) By Application: Oncology; Metabolic Disease; Neurological Disease

3) By End User: Hospitals; Cancer Research Institutes; Diagnostic Labs

Subsegments:

1) By Safety Biomarkers: Toxicity Biomarkers; Organ-Specific Safety Biomarkers; Drug-Induced Injury Biomarkers

2) By Efficacy Biomarkers: Predictive Biomarkers; Prognostic Biomarkers; Pharmacodynamic Biomarkers

3) By Validation Biomarkers: Genomic Biomarkers; Proteomic Biomarkers; Metabolomic Biomarkers

What Key Trends Are Driving Growth In The Diagnostic Biomarkers Market?

Key companies in the diagnostic biomarkers market are working on non-invasive testing innovations such as blood-based biomarker diagnostics to improve patient access and support personalized care. These blood tests detect diseases like Alzheimer’s by identifying specific biomarkers. In July 2023, US-based Quanterix Corporation introduced LucentAD, a blood test that helps diagnose Alzheimer’s in patients showing early symptoms. The test identifies plasma levels of p-Tau 181, a key Alzheimer’s indicator, and provides a simpler, less invasive diagnostic method than traditional approaches like spinal taps or brain scans.

Who Are The Major Stakeholders Operating In The Diagnostic Biomarkers Market?

Major companies operating in the diagnostic biomarkers market are Johnson & Johnson Services Inc., F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, PerkinElmer Inc., Siemens Healthineers AG, Merck KGaA, Agilent Technologies Inc., Charles River Laboratories International Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Qiagen N.V., Myriad Genetics Inc., Meso Scale Diagnostics LLC, EKF Diagnostics Holdings Plc, Sino Biological Inc., Enzo Biochem Inc., Biomarker Technologies Inc., Cisbio Bioassays, Signosis Inc., Epigenomics AG, LifeSign LLC, Banyan Biomarkers Inc., Biosims Technologies SAS

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/diagnostic-biomarkers-global-market-report

How Do Regional Dynamics Influence The Diagnostic Biomarkers Market Performance?

North America was the largest region in the diagnostic biomarkers market in 2024. The regions covered in the diagnostic biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=21171&type=smp

Browse Through More Reports Similar to the Global Diagnostic Biomarkers Market 2025, By The Business Research Company

Biomarkers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/biomarkers-global-market-report

Renal Biomarkers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/renal-biomarkers-global-market-report

Non Alcoholic Steatohepatitis Biomarkers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/non-alcoholic-steatohepatitis-biomarkers-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model